Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

Immunogenicity and reactogenicity study of a new formulation of GSK Biologicals' DTPa-HBV-IPV/Hib vaccine administered as a booster dose to 18-23 months old children
Combined Diphtheria, Tetanus, Acellular Pertussis Adsorbed, Hepatitis B (Recombinant), Inactivated Polio Vaccine
110478
NCT00611559
Acellular pertussis; Diphtheria; Hepatitis B; Poliomyelitis; Tetanus
Phase 4
 
May 2013

Powered by ideaPoint, Inc.